Vyera Pharmaceuticals is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City, U.S. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.
The company has two marketed products: Daraprim, for the treatment of toxoplasmosis, and Vecamyl for the treatment of hypertension. The company was widely criticized for raising the price of daraprim by 5456% following its acquisition of rights to the drug in 2015. After the price raise of the drug, the company's stocks dropped around 10%. CEO Martin Shkreli faced immense criticism for his actions. The company was named after Alan Turing, the computer scientist.
Highest paying job titles at Turing include Software Engineer, Back-End Software Engineer, and Full Stack Engineer